Hayley Suen

Camperdown, NSW 2050, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma.

A liquid biopsy to detect multidrug resistance and disease burden in multiple myeloma.

Journal: Blood cancer journal

Published: July 09, 2019

The T Cell in Myeloma.

The T Cell in Myeloma.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 28, 2016

Isolation of Human CD138(+) Microparticles from the Plasma of Patients with Multiple Myeloma.

Isolation of Human CD138(+) Microparticles from the Plasma of Patients with Multiple Myeloma.

Journal: Neoplasia (New York, N.Y.)

Published: September 16, 2015

A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset.

A CD2 high-expressing stress-resistant human plasmacytoid dendritic-cell subset.

Journal: Immunology and cell biology

Published: July 08, 2015

Using digital polymerase chain reaction to detect minimal residual disease in myeloma by identifying FGFR3 up-regulation.

Using digital polymerase chain reaction to detect minimal residual disease in myeloma by identifying FGFR3 up-regulation.

Journal: Leukemia & lymphoma

Published: February 05, 2015

Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma.

Myeloid derived suppressor cells are numerically, functionally and phenotypically different in patients with multiple myeloma.

Journal: Leukemia & lymphoma

Published: March 15, 2014

Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state.

Myeloma skews regulatory T and pro-inflammatory T helper 17 cell balance in favor of a suppressive state.

Journal: Leukemia & lymphoma

Published: July 20, 2013

Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma.

Trogocytosis generates acquired regulatory T cells adding further complexity to the dysfunctional immune response in multiple myeloma.

Journal: Oncoimmunology

Published: December 25, 2012

CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis.

CD86+ or HLA-G+ can be transferred via trogocytosis from myeloma cells to T cells and are associated with poor prognosis.

Journal: Blood

Published: June 19, 2012

Showing 1-9 of 9

Last Updated: 09/26/2026